Biotech Values

[flatlander_60048]

Dew

Your post prompted me to register on ihub. Do you really feel that the EMEA review of GTCB is no more political than any other drug approval. Looking at the way they have reacted to genetically engineered products makes me think it likely to be viewed in a different more cautious light. You indicated in a previous yahoo post that you felt blood derived protein products held an equivalent if not greater risk (correct me if I paraphrased incorrectly). However, aren't the recent fears of bird flu and swine flu likely to create some level of trepedation on the EMEA's part.

I'm long GTCB but think its prudent to trade around my core position in order to offset some of the volatility and uncertainty on the EMEA decision.

Good Luck

FL